This TYK2 signal has been previously reported to be associated with reduced risk of psoriasis, psoriatic arthropathy, type 1 diabetes, systemic lupus erythematosus and RA as well as other autoimmune inflammatory conditions13,14 (Table 2). Here, TYK2 is linked to systemic lupus erythematosus.